Gene therapy for child dementia faces financial hurdles outside United States
A new gene therapy for a rare child dementia is approved in the US, but access for international patients remains uncertain due to costs.
FTMQ Health, written by our newsroom0 views

The mother of a five-year-old boy with a rare form of dementia faces a cost of almost 3 million pounds for a life-saving gene therapy. Tate McDaid, from Swansea, was diagnosed with Sanfilippo Syndrome at age four. The BBC reported that the first gene therapy to treat the condition in children received approval in the United States in September 2026. [1]
Sanfilippo Syndrome is a form of dementia that affects just over 100 children in the United Kingdom. According to the BBC, the newly approved gene therapy is set to cost 2.95 million pounds per child. It remains unclear how families outside the United States will fund the procedure. [1]
Tate McDaid's mother, Tammy McDaid, stated she spent months praying for the treatment to be approved. Health officials in Wales are currently speaking with authorities in the United States to explore potential pathways for Tate McDaid to access the therapy, the BBC reported. [1]
In short
- A gene therapy to treat Sanfilippo Syndrome in children was approved in the United States in September 2026.
- Sanfilippo Syndrome affects just over 100 children in the United Kingdom.
- The gene therapy treatment is set to cost 2.95 million pounds per child.
- Welsh health officials are in discussions with US officials to seek treatment access for a five-year-old patient.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]There's finally a treatment for my five-year-old's dementia - but it'll cost me £3mBBC Health, 10d ago (the report this story comes from)
Background
- [2]Finally Over It on Wikipedia
Our newsroom writes these reports with the help of software, from the 2 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- CAR T cell therapy analysis reveals high inflammation but low mortalityMedical Science, 4h ago
- Oregon hospital financial aid mandate faces pushback after initial successHealth Care, 27d ago
- Rural Welsh health board faces backlash over community hospital bed cutsTop Stories, 14d ago
- Parents lack confidence in spotting childhood cancer symptoms UK study findsTop Stories, 37d ago
- Walnut study links daily intake to higher immune system antibody levelsTop Stories, 16d ago
More in Top Stories
- United States updates federal health data privacy regulations for patient records4h ago
- Apple launches large study to evaluate health artificial intelligence app4h ago
- United States loses official measles elimination status following severe outbreak4h ago
- GLP1 weight loss drugs linked to nutrient shortages in exploratory study4h ago
- Large and small waist sizes linked to higher death risk4h ago
- UK government to end Palantir NHS England contract in 20291d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.